serum erythropoietin level patient intens chemotherapi radiotherapi potenti role recombin human erythropoietin rhepo patient intens cytotox therapi endogen level epo patient bone marrow transplant bmt seventeen patient underw allogen bmt underw autolog bmt averag unit red blood cell rbc patient mean rbc transfus requir autolog bmt patient allogen recipi group compar hematocrit epo level radioimmunoassay ria patient baselin serum epo level time admiss hospit subsequ sampl hour chemotherapi and/or radiotherapi day bmt hematocrit hct patient initi serum creatinin equal mg/dl consider differ absolut epo level individu characterist pattern admiss hospit initi cytotox therapi averag hct averag epo level mean serum epo level day post-bmt mu/ml averag hct day day post-bmt differ averag serum epo level period day post-bmt mean epo level low refer popul bone marrow failur normal control cytotox therapi endogen epo respons week post-bmt clinic trial efficaci administr rhepo treatment anemia cytotox therapi 